Entrada Therapeutics, Inc. financial data

Symbol
TRDA on Nasdaq
Location
One Design Center Place, Suite 17 500, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.52K % +329%
Debt-to-equity 19.7 % -64.3%
Return On Equity -26.4 % -264%
Return On Assets -22.1 % -313%
Operating Margin -198 % -836%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38.2M shares +2.14%
Common Stock, Shares, Outstanding 38.2M shares +2.19%
Entity Public Float 393M USD -8.98%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 41.5M shares +2.05%
Weighted Average Number of Shares Outstanding, Diluted 41.5M shares +2.05%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 61.5M USD -71.4%
Research and Development Expense 142M USD +17.9%
General and Administrative Expense 41.4M USD +11%
Operating Income (Loss) -122M USD -310%
Income Tax Expense (Benefit) -1.04M USD -105%
Net Income (Loss) Attributable to Parent -103M USD -288%
Earnings Per Share, Basic -2 USD/shares -262%
Earnings Per Share, Diluted -2 USD/shares -265%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 93.3M USD +19.5%
Cash, Cash Equivalents, and Short-term Investments 327M USD -27.3%
Assets, Current 338M USD -27.3%
Property, Plant and Equipment, Net 8.41M USD -22.1%
Operating Lease, Right-of-Use Asset 62.1M USD -15.8%
Other Assets, Noncurrent 163K USD -78.2%
Assets 413M USD -25.5%
Accounts Payable, Current 3.17M USD +145%
Employee-related Liabilities, Current 6.95M USD +5.65%
Accrued Liabilities, Current 15.5M USD +15.9%
Liabilities, Current 24M USD -66%
Operating Lease, Liability, Noncurrent 48.1M USD -10.3%
Liabilities 72.2M USD -45.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 621K USD -36.1%
Retained Earnings (Accumulated Deficit) -234M USD -79.3%
Stockholders' Equity Attributable to Parent 341M USD -19.3%
Liabilities and Equity 413M USD -25.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -38.5M USD -50.9%
Net Cash Provided by (Used in) Financing Activities 350K USD +69.9%
Net Cash Provided by (Used in) Investing Activities 4.78M USD -81.7%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 38.2M shares +2.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -33.4M USD -4102%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 97.2M USD +18.6%
Deferred Tax Assets, Valuation Allowance 62.9M USD -19.2%
Deferred Tax Assets, Gross 84.7M USD -17.4%
Operating Lease, Liability 59.2M USD -13.2%
Depreciation 4.29M USD +21.3%
Payments to Acquire Property, Plant, and Equipment 1.14M USD +36.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -104M USD -284%
Lessee, Operating Lease, Liability, to be Paid 80.4M USD -15%
Property, Plant and Equipment, Gross 18.6M USD -3.5%
Operating Lease, Liability, Current 4.35M USD -43.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.83M USD -32.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 12M USD -7.92%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.2M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.08M USD +2.91%
Deferred Tax Assets, Operating Loss Carryforwards 1.26M USD -65.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.35M USD +2.93%
Operating Lease, Payments 2.28M USD +24.1%
Additional Paid in Capital 574M USD +4%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 20M USD +17%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%